Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The healthcare for transgender veterans could be better with a more unified team approach.

Finasteride effectively treats hair loss in transgender men with few side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

The regulations aimed to improve domiciliary care in Wales by ensuring better work conditions and visit schedules.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Testosterone therapy in transgender men can lead to hair loss, with the risk increasing over time and influenced by family history.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The surgical technique of scalp advancement and pretrichial brow lift shortens the forehead and lifts brows, is good for women and transgender women with high foreheads, but not recommended for men and has some risks.

Forehead modification greatly increases the perception of femininity and is a safe procedure.